A. Eisbruch et al., CHEMOTHERAPY FOLLOWED BY ACCELERATED FRACTIONATED RADIATION FOR LARYNX PRESERVATION IN PATIENTS WITH ADVANCED LARYNGEAL-CANCER, Journal of clinical oncology, 14(8), 1996, pp. 2322-2330
Purpose: Larynx preservation in advanced, resectable laryngeal cancer
may be achieved using induction chemotherapy (CT) followed in respondi
ng patients by definitive radiation (RT). To address potential acceler
ated repopulation of clonogenic tumor cells during the prolonged total
treatment time, we studied the feasibility of accelerated fractionate
d RT after CT. Methods: patients with advanced laryngeal cancer receiv
ed two cycles of cisplatin 100 mg/m(2) and fluorouracil (5-Fu) 1,000 m
g/m(2)/d for 5 days. Responding patients received a third cycle after
which those who had complete response or tumor down-staging to T1 proc
eeded with accelerated RT: 70.4 Gy delivered over 5.5 weeks. patients
who achieved a lesser response to CT underwent total laryngectomy and
postoperative RT. Results: Thirty-three patients were accrued. Three d
ied during the course of CT and two declined definitive treatment afte
r CT. Twenty-one patients held a major response to CT, 20 of whom rece
ived accelerated RT. Median weight loss during RT was 11%. Late severe
morbidity was observed in five patients (25%). All four patients who
underwent salvage laryngectomy after accelerated RT experienced major
postoperative complications, The locoregional failure rate was 25%. Th
e larynx was preserved in 48% of the total study population and in 80%
of the patients irradiated according to the study protocol. Conclusio
n: Accelerated RT after CT as delivered in this study may increase bot
h acute and long-term morbidity rates compared with studies using stan
dard RT after CT, it did nor seem to improve local/regionol tumor cont
rol or survival despite stringent patient selection criteria. (C) 1996
by American Society of Clinical Oncology.